Communiqués Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Installations et services en soins de santé

Marché Fermé - NYSE Autres places de cotation 22:00:02 30/07/2026			Pré-ouverture 14:30:19
234,30 ^USD	-0,39 %		223,44	-4,64 %

30/07	QUEST DIAGNOSTICS INCORPORATED : Argus reste à l'achat	ZM
30/07	Labcorp relève ses prévisions de bénéfice annuel grâce à la solidité de la demande de tests	RE

Communiqués

30/07	Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics	PR
23/07	Quest Diagnostics: Q2 Earnings Snapshot	AQ
23/07	Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026	PR
10/07	One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns	PR
08/07	Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI	PR
01/07	United States Circuit Court Issues Positive Ruling For Fiduciaries And Adherence To Good Process	AQ
24/06	Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing	PR
18/06	UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics	PR
17/06	Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026	PR
16/06	Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report	PR
19/05	Quest Diagnostics Declares Quarterly Cash Dividend	PR
27/04	Quest Diagnostics Prices $500 Million of Senior Notes	PR
21/04	Quest Diagnostics: Q1 Earnings Snapshot	AQ
21/04	Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026	PR
16/04	City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers	PR
19/03	Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026	PR
12/03	Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors	PR
02/03	Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results	PR
26/02	Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer	PR
25/02	Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference	PR
10/02	Quest Diagnostics: Q4 Earnings Snapshot	AQ
10/02	Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share	PR
10/02	Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization	PR
02/02	Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease	PR
21/01	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year	PR